Finance

Lists
Why is 543904 down ३.३९%?
Dive Deeper
543904:BOM
म्यानकाइन्ड फार्मा
₹ २,२७५.००
-३.३९%
(-७९.८०) 1D
अक्टोबर १६, १५:५०:४० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543904...
Open
₹ २,३५४.६०
High
₹ २,३५५.००
Low
₹ २,२६९.००
Mkt. cap
९.३७ खरब
Avg. vol.
४०.८९ हजार
Volume
३२.८६ हजार
P/E ratio
४६.०३
52-wk high
₹ २,६४०.३०
52-wk low
₹ १,९०९.९०
EPS
₹ ४९.४२
No. of employees
२० हजार
Open
₹ २,३५४.६०
High
₹ २,३५५.००
Low
₹ २,२६९.००
Mkt. cap
९.३७ खरब
Avg. vol.
४०.८९ हजार
Volume
३२.८६ हजार
P/E ratio
४६.०३
52-wk high
₹ २,६४०.३०
52-wk low
₹ १,९०९.९०
EPS
₹ ४९.४२
No. of employees
२० हजार
News stories
From web sources and news partners
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About म्यानकाइन्ड फार्मा
CEORajeev Juneja | Sheetal Arora
Employees२०.५ हजार
Founded१९९१
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३६.९७ अरब
३५.६७ अरब
३४.४३ अरब
४०.३१ अरब
Cost of goods sold
१०.६२ अरब
९.७८ अरब
११.७१ अरब
१०.९८ अरब
Cost of revenue
१०.६२ अरब
९.७८ अरब
११.७१ अरब
१०.९८ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८.२५ अरब
८.२४ अरब
१५.८० अरब
९.१४ अरब
Operating expense
१९.३५ अरब
१८.९२ अरब
१४.७७ अरब
२१.०२ अरब
Total operating expenses
२९.९८ अरब
२८.७० अरब
२६.४८ अरब
३२.०० अरब
Operating income
७.०० अरब
६.९७ अरब
७.९५ अरब
८.३० अरब
Other non operating income
९१.८७ करोड
७२.७५ करोड
-२.३१ अरब
४५.०० करोड
EBT including unusual items
६.२४ अरब
५.०९ अरब
६.५९ अरब
७.६९ अरब
EBT excluding unusual items
६.२४ अरब
६.१६ अरब
५.५९ अरब
७.६९ अरब
Income tax expense
१.०४ अरब
९५.१२ करोड
९९.७५ करोड
१.९५ अरब
Effective tax rate
१६.६४%
१८.६९%
१५.१३%
२५.३९%
Other operating expenses
८.८८ अरब
८.४६ अरब
-३.२६ अरब
९.६३ अरब
Net income
५.१२ अरब
४.०९ अरब
५.५४ अरब
५.६८ अरब
Net profit margin
१३.८४%
११.४६%
१६.१०%
१४.०९%
Earnings per share
१२.३८
११.९९
१३.८९
१३.७४
Interest and investment income
-
-
५८.०५ करोड
-
Interest expense
-१.७० अरब
-१.५७ अरब
-१.३६ अरब
-१.१० अरब
Net interest expenses
-१.७० अरब
-१.५७ अरब
-७७.८२ करोड
-१.१० अरब
Depreciation and amortization charges
२.२२ अरब
२.२३ अरब
२.२३ अरब
२.२६ अरब
EBITDA
९.२० अरब
८.४२ अरब
९.९७ अरब
१०.३३ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू